Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
The Canadian Journal of Urology|August 26, 2023
How I Do It: Maintenance avelumab for advanced urothelial carcinomaAly-Khan A LalaniExpert Opinion on Pharmacotherapy|November 10, 2018
Systemic treatments for metastatic urothelial carcinomaAly-Khan A Lalani, Guru P SonpavdeHuman Vaccines & Immunotherapeutics|February 12, 2023
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinomaPooya Dibajnia, Luisa M Cardenas, Aly-Khan A LalaniEuropean Urology Focus|November 30, 2017
Immunotherapy in the ElderlyAly-Khan A Lalani, Dominick Bossé, Bradley A McGregor, et al.Cureus|January 7, 2026
SMARCB1-Deficient Renal Medullary Carcinoma: A Case Report Highlighting the Value of History and Race InformationHabibat F Kolawole, Luisa Cardenas, Andrea Simmonds, et al.European Urology Focus|March 5, 2019
State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy EraZiad Bakouny, Ronan Flippot, David A Braun, et al.Current Oncology (Toronto, Ont.)|March 11, 2021
Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case ReportSuraya Bondy, Camilla Tajzler, Sebastien J Hotte, et al.Clinical Genitourinary Cancer|June 25, 2017
Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Rana R McKay, Xun Lin, et al.Current Oncology (Toronto, Ont.)|August 25, 2022
Next Wave of Targets in the Treatment of Advanced Renal Cell CarcinomaLuisa M Cardenas, Jasna E Deluce, Shahrukh Khan, et al.Urologic Oncology|September 17, 2024
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trialsLaura Oscar-Thompson, Carlos Riveros, Guru Sonpavde, et al.Pageof 6